Non-tumoral liver dose toxicity thresholds
non-segmental, toxicities
ADVERSE EVENTS
All analyzed dosimetric NTLD predicted serious grade 3 adverse events at 3 and 6 months for the non-segmental cohort (Table Non-tumoral liver dose (NTLD) predicts severe clinical toxicities at 3 months (